Living Breath Project Offers Pain-Free Detox for Heroin

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Living Breath Project Offers Pain-Free Detox for Heroin Addicts

NEW YORK, NY--(Marketwired - May 31, 2013) - Living Breath Project ( OTCQB : DMAX ) is bringing the answer to the world's heroin epidemic with its powerful, pain-free detox program. Offered at only $595 per program on its website, www.livingbreathproject.com , this low-cost solution picks up where traditional treatments -- from 28-day rehab facilities to jail -- leave off.

The Living Breath Project's program, called the "Cleansing Heroin Addiction Protocol," can easily be practiced at home, within facilities or as part of private and group therapy sessions without any complications that typically may arise while detoxing from heroin. It starts with a brief 4-day pain-reduction program during the first days of detox, and follows with a 12-day program that addresses the underlying cause of the addiction.

The key to the Protocol is the exclusive Living Breath Process ®, which combines self-analysis, a special three-part breath and positive reinforcement, to clear the mind of the negative unconscious language that leads to self-sabotaging behaviors.

Lindsey Smith, 19, is the latest heroin addict to participate in the Cleansing Heroin Addiction Protocol. An example of the growing heroin use among teens, Smith had attempted rehab several times. This was her final effort to save her life. Less than a week ago, Smith flew from her hometown in Santa Cruz, Calif., to New York to begin her treatment at the Living Breath Project Wellness House. Today she is heroin-free.

"I had no withdrawals this time," said Smith. "Before when I would detox off heroin it was the worst thing ever. It was like having the flu times 100. Even when given Subutex to alleviate the detox symptoms, I would go through a second round of detoxing from the Subutex. Here I've had no detox symptoms; I've felt at peace."

"I most recently went to rehab about two months ago and the day I got out I relapsed. Here, I've had no desire to go back to heroin," Smith continued. "This process is just not comparable to rehab; it's so much more powerful."

"Traditional drug-rehabilitation programs have an 81% failure rate because they don't address the underlying cause of addiction," said Genie O'Malley, founder and CEO of the Living Breath Project. "Our program cleanses the trauma of addiction and creates a positive and uplifting emotional transformation."

"It's taken us 17 years to bring forth this powerful solution to the drug epidemic," continued O'Malley. "Addiction costs this country $400 trillion dollars in medical fees, lost wages, incarceration costs and more. It's our mission to reduce this cost and help people heal from their addiction with such a simple program."

"It is our global mission to change the conversation about drugs -- within addicts, by addicts and about addicts."

For more information on the Living Breath Project and its founder, please visit www.livingbreathproject.com or follow the company on its Facebook fan page, www.facebook.com/livingbreathproject .

About The Living Breath Project: The Living Breath Project, Inc. ( OTCQB : DMAX ) is a wellness and lifestyle company that provides services known as the Living Breath Process® . This integrated and proprietary process, founded and pioneered by the company's CEO Genie O'Malley, provides customers with therapies, as well as a medical support network, that utilizes the company's innovative three-part breath aimed at improving emotional wellness and, ultimately, quality of life. The Living Breath Project's products -- sold on www.livingbreathproject.com -- focus on 49 key emotional areas, collectively named the Living Breath Protocols , ranging from addiction, to depression, to post-traumatic stress, and many more.

Contact: Jessica Forman Living Breath Project 646.929.4842 Email Contact Andrea Miller Living Breath Project 631.745.3773 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 17

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 15

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 19

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 16

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 15

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 13

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 9

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 11

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 17

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Guaranty Bancshares Sale Investigation by Top Legal Team

Updated Category News Views 145

Understanding the Sale of Guaranty Bancshares, Inc. The recent announcement regarding the proposed sale of Guaranty Bancshares, Inc. to Glacier Bancorp, Inc. has garnered significant attention. Shareholders will reportedly receive 1.0000 share of Glacier stock for each share they hold in Guaranty. This transaction raises important questions regarding its valuation and the...

Continue Reading
Ascenz Marorka Enhances Fleet Performance Monitoring in the Americas

Updated Category News Views 147

Ascenz Marorka Enhances Fleet Performance Monitoring in the Americas Ascenz Marorka, the smart shipping arm of GTT, has recently made strides by expanding its Real-Time Fleet Performance Monitoring Service to encompass the Americas. This strategic development follows the success of deployments in renowned maritime hubs, showcasing Ascenz Marorka's commitment to enhancing...

Continue Reading
Ares Management Expands Renewable Energy Footprint with New Acquisition

Updated Category News Views 334

Ares Management Expands Renewable Energy Footprint Recently, Ares Management Corporation (NYSE: ARES) announced a remarkable acquisition that underscores their commitment to renewable energy. A fund managed under the Ares Infrastructure Opportunities strategy has secured a 49% stake in a diverse energy asset portfolio valued at approximately $2.9 billion. This strategic...

Continue Reading
RLX Technology Set to Share Financial Insights This Quarter

Updated Category News Views 145

RLX Technology to Announce Third Quarter Financial Results Internationally recognized for its innovative approach, RLX Technology Inc. (NYSE: RLX) is gearing up to unveil its financial performance for the third quarter, which will end September 30, 2025. This announcement will occur just before the U.S. markets open on November 14, 2025. As a global leader in the e-vapor...

Continue Reading
Grok AI Gets Federal Approval: Key Insights for Musk and Trump

Updated Category News Views 302

Grok AI Federal Approval Marks a New Era The approval for Elon Musk's AI chatbot, Grok, to be utilized by all federal agencies represents a groundbreaking development in how artificial intelligence can enhance government operations. The General Services Administration (GSA) has granted this approval along with special provisions from Musk's AI company, xAI. Understanding...

Continue Reading